BOCA RATON, FLORIDA - INmune Bio , Inc. (NASDAQ: NASDAQ:INMB), a clinical-stage biotechnology company with a market capitalization of $212.74 million, announced today its plans to submit regulatory ...
San Antonio school districts are seeing a spike in students with dyslexia while working to comply with a new state law requiring changes to instruction.